Search

everythinglearnresearchcommunity

for

Search:↓

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Skin symptoms can indicate endocrine disorders and have various treatments.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

IFHUT shows better hair growth than FUE, but needs improvements in positioning, speed, and accuracy.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Bald men may have a lower risk of testicular cancer.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

People with hair loss feel more depressed and anxious, especially women, and need help managing emotions and beliefs about their condition.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

Various treatments help hair growth, but more research needed for safety and effectiveness.